These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10364203)

  • 41. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
    Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
    Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity.
    Druley TE; Stein WD; Roninson IB
    Biochemistry; 2001 Apr; 40(14):4312-22. PubMed ID: 11284687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new anthracycline with potent anti-leukemic activity overcomes P-glycoprotein multidrug resistance.
    Andrivon W; Monneret C; Nafziger J; Florent JC; Guillosson JJ
    Leuk Res; 1998 Aug; 22(8):719-25. PubMed ID: 9680099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insights Into the Molecular Mechanism of Triptan Transport by P-glycoprotein.
    Wilt LA; Nguyen D; Roberts AG
    J Pharm Sci; 2017 Jun; 106(6):1670-1679. PubMed ID: 28283434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of tumor cell resistance to 4'-deoxy-4'-iododoxorubicin developed in Ehrlich ascites cells in vivo.
    Friche E; Danks MK; Beck WT
    Cancer Res; 1992 Oct; 52(20):5701-6. PubMed ID: 1356619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. P-glycoprotein-mediated colchicine resistance in different cell lines correlates with the effects of colchicine on P-glycoprotein conformation.
    Druley TE; Stein WD; Ruth A; Roninson IB
    Biochemistry; 2001 Apr; 40(14):4323-31. PubMed ID: 11284688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
    Lehne G; De Angelis P; Clausen OP; Rugstad HE
    Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of drug interaction sites in P-glycoprotein.
    Greenberger LM
    Methods Enzymol; 1998; 292():307-17. PubMed ID: 9711563
    [No Abstract]   [Full Text] [Related]  

  • 49. A ligand-dependent conformational change of the Na+/galactose cotransporter of Vibrio parahaemolyticus, monitored by tryptophan fluorescence.
    Veenstra M; Turk E; Wright EM
    J Membr Biol; 2002 Feb; 185(3):249-55. PubMed ID: 11891582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity.
    Mülder HS; Dekker H; Pinedo HM; Lankelma J
    Biochem Pharmacol; 1995 Sep; 50(7):967-74. PubMed ID: 7575681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conformational changes in a multidrug resistance ABC transporter DrrAB: Fluorescence-based approaches to study substrate binding.
    Rahman SJ; Kaur P
    Arch Biochem Biophys; 2018 Nov; 658():31-45. PubMed ID: 30243711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
    Sehested M; Skovsgaard T; Jensen PB; Demant EJ; Friche E; Bindslev N
    Br J Cancer; 1990 Jul; 62(1):37-41. PubMed ID: 1975202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and localization of three photobinding sites of iodoarylazidoprazosin in hamster P-glycoprotein.
    Isenberg B; Thole H; Tümmler B; Demmer A
    Eur J Biochem; 2001 May; 268(9):2629-34. PubMed ID: 11322883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.
    Smith CD; Myers CB; Zilfou JT; Smith SN; Lawrence DS
    Oncol Res; 2000; 12(5):219-29. PubMed ID: 11417747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The mechanism of action of multidrug-resistance-linked P-glycoprotein.
    Sauna ZE; Smith MM; Müller M; Kerr KM; Ambudkar SV
    J Bioenerg Biomembr; 2001 Dec; 33(6):481-91. PubMed ID: 11804190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug-Induced Conformational Dynamics of P-Glycoprotein Underlies the Transport of Camptothecin Analogs.
    Mensah GAK; Schaefer KG; Bartlett MG; Roberts AG; King GM
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.
    Rhodes T; Barrand MA; Twentyman PR
    Br J Cancer; 1994 Jul; 70(1):60-6. PubMed ID: 7912544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ATP hydrolysis-dependent multidrug efflux transporter: MDR1/P-glycoprotein.
    Kimura Y; Matsuo M; Takahashi K; Saeki T; Kioka N; Amachi T; Ueda K
    Curr Drug Metab; 2004 Feb; 5(1):1-10. PubMed ID: 14965247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.
    Loo TW; Clarke DM
    Biochemistry; 1994 Nov; 33(47):14049-57. PubMed ID: 7947814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.